Hypercalcaemic crisis after excessive topical use of a vitamin D derivative
- 1 March 1994
- journal article
- case report
- Published by Wiley in Journal of Internal Medicine
- Vol. 235 (3) , 281-282
- https://doi.org/10.1111/j.1365-2796.1994.tb01074.x
Abstract
Topical application of the vitamin D analogue calci‐potriol has been found to be of clinical value in the treatment of dermatological disorders. This is considered to be safe with respect to alterations in calcium homeostasis. We report a 17‐year‐old female patient who developed hypercalcaemic crisis after excessive use of calcipotriol for ichthyosis. The clinical condition and serum calcium improved after cessation of calciprotiol treatment and rehydration with intravenous fluids and electrolytes. The case emphasizes the importance of limiting the topical use of calcipotriol as recommended by the manufacturer.Keywords
This publication has 6 references indexed in Scilit:
- Vitamin D analogues and psoriasisBritish Journal of Dermatology, 1992
- Calcipotriol and hypercalcaemiaPublished by Elsevier ,1991
- Calcipotriol (MC 903): Pharmacokinetics in rats and biological activities of metabolites: A comparative study with 1,25(OH)2D3Biochemical Pharmacology, 1991
- Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Results of an open study.Acta Dermato-Venereologica, 1991
- Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivoBiochemical Pharmacology, 1988
- Case Report Vitamin A Toxicity and HypercalcemiaThe Lancet Healthy Longevity, 1982